Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 5471: PRT2527, a novel highly selective cyclin-dependent kinase 9 (CDK9) inhibitor, is active in preclinical models of prostate cancer

Cancer Res (2022) 82 (12_Supplement): 5471.

https://doi.org/10.1158/1538-7445.AM2022-5471

Published: 15 June 2022

View articletitled, Abstract 5471: PRT2527, a novel highly selective cyclin-dependent kinase 9 (CDK9) inhibitor, is active in preclinical models of prostate cancer

Journal Articles

Abstract LB-201: ERG lysine methylation promotes prostate cancer progression in ERG transgenic mice

Marita Zoma, Dheeraj Shinde, Domenico Albino, Simone Mosole, Jacopo Sgrignani, Andrea Cavalli, Carlo V. Catapano, Giuseppina M. Carbone

Cancer Res (2018) 78 (13_Supplement): LB-201.

https://doi.org/10.1158/1538-7445.AM2018-LB-201

Published: 01 July 2018

View articletitled, Abstract LB-201: ERG lysine methylation promotes prostate cancer progression in ERG transgenic mice

Journal Articles

Abstract 2900: Sigma-1 receptor control tumorigenic and stem cell-like phenotype in human cancers

Gianluca Civenni, Martina Marchetti, Shusil Pandit, Celeste De Monte, Federica Sereni, Jessica Merulla, Sabrina Zadic, Marco Losa, Sara Allegrini, Domenico Albino, Sarah Mapelli, Erik Laurini, Bernhard Wunsch, Sabrina Pricl, Giuseppina M. Carbone, Carlo V. Catapano

Cancer Res (2017) 77 (13_Supplement): 2900.

https://doi.org/10.1158/1538-7445.AM2017-2900

Published: 01 July 2017

View articletitled, Abstract 2900: Sigma-1 receptor control tumorigenic and stem cell-like phenotype in human cancers

Journal Articles

Abstract LB-152: EZH2-induced lysine methylation and ERG-EZH2 genomic co-occupancy set the basis for extensive transcriptome reprogramming and prostate cancer progression

Giuseppina M. R. Carbone, Laura Curti, Marita Zoma, Abhishek Mitra, Dheeraj Shinde, Domenico Albino, Simona Rossi, Gianluca Civenni, George N. Thalmann, Giovanna Chiorino, Carlo Catapano

Cancer Res (2016) 76 (14_Supplement): LB-152.

https://doi.org/10.1158/1538-7445.AM2016-LB-152

Published: 15 July 2016

View articletitled, Abstract LB-152: EZH2-induced lysine methylation and ERG-EZH2 genomic co-occupancy set the basis for extensive transcriptome reprogramming and prostate cancer progression

Journal Articles

Abstract 3343: Targeting the Lin28A/B axis reverts stem cell-like phenotype and tumor-initiating properties in prostate cancer

Domenico Albino, Gianluca Civenni, Cecilia Dallavalle, Martina Roos, Hartmut Jahns, Jonathan Hall, Giuseppina M. Carbone, Carlo V. Catapano

Cancer Res (2016) 76 (14_Supplement): 3343.

https://doi.org/10.1158/1538-7445.AM2016-3343

Published: 15 July 2016

View articletitled, Abstract 3343: Targeting the Lin28A/B axis reverts stem cell-like phenotype and tumor-initiating properties in prostate cancer

Journal Articles

Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer

Domenico Albino, Gianluca Civenni, Cecilia Dallavalle, Martina Roos, Hartmut Jahns, Laura Curti, Simona Rossi, Sandra Pinton, Gioacchino D'Ambrosio, Fausto Sessa, Jonathan Hall, Carlo V. Catapano, Giuseppina M. Carbone

Cancer Res (2016) 76 (12): 3629–3643.

https://doi.org/10.1158/0008-5472.CAN-15-2665

Published: 14 June 2016

View articletitled, Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 2625: Targeting prostate cancer stem cells (CSCs) with the novel BET bromodomain (BRD) protein inhibitor OTX015

Gianluca Civenni, Silvia Pedrani, Sara Allegrini, Antonina Bruccoleri, Domenico Albino, Sandra Pinton, Ramon Garcia-Escudero, L'Houcine Ouafik, Esteban Cvitkovic, Giuseppina M. Carbone, Carlo V. Catapano

Cancer Res (2015) 75 (15_Supplement): 2625.

https://doi.org/10.1158/1538-7445.AM2015-2625

Published: 01 August 2015

View articletitled, Abstract 2625: Targeting prostate cancer stem cells (CSCs) with the novel BET bromodomain (BRD) protein inhibitor OTX015

Journal Articles

Abstract 4968: microRNA-mediated silencing of COP1 and altered ubiquitination of key oncogenic transcription factors promote cancer stem cell (CSC) phenotype and prostate cancer progression

Cecilia Dallavalle, Domenico Albino, Gianluca Civenni, Laura Curti, Paola Ostano, Maurizia Mello-Grand, Ramon Garcia-Escudero, Giovanna Chiorino, Carlo V. Catapano, Giuseppina M. R. Carbone

Cancer Res (2015) 75 (15_Supplement): 4968.

https://doi.org/10.1158/1538-7445.AM2015-4968

Published: 01 August 2015

View articletitled, Abstract 4968: microRNA-mediated silencing of COP1 and altered ubiquitination of key oncogenic transcription factors promote cancer stem cell (CSC) phenotype and prostate cancer progression

Journal Articles

Abstract 1451: MicroRNAs regulated by ESE3/EHF control important mediators of epithelial cell differentiation and stemness in prostate tumors

Cecilia Dallavalle, Domenico Albino, Gianluca Civenni, Paola Ostano, Davide Genini, Ramon Garcia-Escudero, Laura Curti, Sandra Pinton, Manuela Sarti, Giovanna Chiorino, Carlo V. Catapano, Giuseppina M. R. Carbone

Cancer Res (2014) 74 (19_Supplement): 1451.

https://doi.org/10.1158/1538-7445.AM2014-1451

Published: 01 October 2014

View articletitled, Abstract 1451: MicroRNAs regulated by ESE3/EHF control important mediators of epithelial cell differentiation and stemness in prostate tumors

Journal Articles

Abstract 1936: The ETS factor ESE3/EHF controls Lin28A and Lin28B and acts as a barrier for stemness in prostate epithelial cells

Domenico Albino, Gianluca Civenni, Mahnaz Nikpour, Carlo V. Catapano, Giuseppina M. R. Carbone

Cancer Res (2014) 74 (19_Supplement): 1936.

https://doi.org/10.1158/1538-7445.AM2014-1936

Published: 01 October 2014

View articletitled, Abstract 1936: The ETS factor ESE3/EHF controls Lin28A and Lin28B and acts as a barrier for stemness in prostate epithelial cells

Journal Articles

RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer

Gianluca Civenni, Anastasia Malek, Domenico Albino, Ramon Garcia-Escudero, Sara Napoli, Stefano Di Marco, Sandra Pinton, Manuela Sarti, Giuseppina M. Carbone, Carlo V. Catapano

Cancer Res (2013) 73 (22): 6816–6827.

https://doi.org/10.1158/0008-5472.CAN-13-0615

Published: 14 November 2013

View articletitled, RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer

Includes: Supplementary data

Journal Articles

ETS Transcription Factor ESE1/ELF3 Orchestrates a Positive Feedback Loop That Constitutively Activates NF-κB and Drives Prostate Cancer Progression

Nicole Longoni, Manuela Sarti, Domenico Albino, Gianluca Civenni, Anastasia Malek, Erica Ortelli, Sandra Pinton, Maurizia Mello-Grand, Paola Ostano, Gioacchino D'Ambrosio, Fausto Sessa, Ramon Garcia-Escudero, George N. Thalmann, Giovanna Chiorino, Carlo V. Catapano, Giuseppina M. Carbone

Cancer Res (2013) 73 (14): 4533–4547.

https://doi.org/10.1158/0008-5472.CAN-12-4537

Published: 15 July 2013

View articletitled, ETS Transcription Factor ESE1/ELF3 Orchestrates a Positive Feedback Loop That Constitutively Activates NF-κB and Drives Prostate Cancer Progression

Includes: Supplementary data

Journal Articles

Abstract B24: Loss of expression of the endogenous ETS factor ESE3/EHF is associated with a distinct tumor subtype with stem-like and basal cell features

Maurizia Mello-Grand, Manuela Sarti, Gioacchino D'Ambrosio, Fausto Sessa, George Thalmann, Giovanna Chiorino, Carlo V. Catapano, Giuseppina MR Carbone, Domenico Albino, Vijay Kumar Singh, Gianluca Civenni, Nicole Longoni, Chiara Ghimenti, Paola Ostano, Sandra Pinton

Cancer Res (2012) 72 (4_Supplement): B24.

https://doi.org/10.1158/1538-7445.PRCA2012-B24

Published: 09 May 2013

View articletitled, Abstract B24: Loss of expression of the endogenous ETS factor ESE3/EHF is associated with a distinct tumor subtype with stem-like and basal cell features

Journal Articles

Abstract 3307: Transcriptional silencing of c-Myc by promoter-directed siRNA efficiently target prostate cancer stem cells.

Gianluca Civenni, Anastasia Malek, Domenico Albino, Manuela Sarti, Sandra Pinton, Stefano Di Marco, Giuseppina M. Carbone, Carlo V. Catapano

Cancer Res (2013) 73 (8_Supplement): 3307.

https://doi.org/10.1158/1538-7445.AM2013-3307

Published: 15 April 2013

View articletitled, Abstract 3307: Transcriptional silencing of c-Myc by promoter-directed siRNA efficiently target prostate cancer stem cells.

Journal Articles

Abstract 3118: ESE1/ELF3 and constitutive activation of NF-kB in human prostate cancer: prognostic relevance and rationale for context-dependent therapeutic strategies.

Nicole Longoni, Domenico Albino, Gianluca Civenni, Sandra Pinton, Maurizia Mello-Grand, Paola Ostano, Gioacchino D’ Ambrosio, Fausto Sessa, George N. Thalmann, Manuela Sarti, Ramon Garcia-Escudero, Francisco Morris, Giovanna Chiorino, Carlo V. Catapano, Giuseppina M. Carbone

Cancer Res (2013) 73 (8_Supplement): 3118.

https://doi.org/10.1158/1538-7445.AM2013-3118

Published: 15 April 2013

View articletitled, Abstract 3118: ESE1/ELF3 and constitutive activation of NF-kB in human prostate cancer: prognostic relevance and rationale for context-dependent therapeutic strategies.

Journal Articles

ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features

Domenico Albino, Nicole Longoni, Laura Curti, Maurizia Mello-Grand, Sandra Pinton, Gianluca Civenni, George Thalmann, Gioacchino D'Ambrosio, Manuela Sarti, Fausto Sessa, Giovanna Chiorino, Carlo V. Catapano, Giuseppina M. Carbone

Cancer Res (2012) 72 (11): 2889–2900.

https://doi.org/10.1158/0008-5472.CAN-12-0212

Published: 31 May 2012

View articletitled, ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features

Includes: Supplementary data

Journal Articles

Abstract 5019: Loss of the ETS transcription factor ESE3 induces epithelial-mesenchimal transition and generates cells with stem cell-like properties

Domenico Albino, Nicole Longoni, Erica Ortelli, Paolo Kunderfranco, Anastasia Malek, Carlo V. Catapano, Giuseppina MR Carbone

Cancer Res (2010) 70 (8_Supplement): 5019.

https://doi.org/10.1158/1538-7445.AM10-5019

Published: 15 April 2010

View articletitled, Abstract 5019: Loss of the ETS transcription factor ESE3 induces epithelial-mesenchimal transition and generates cells with stem cell-like properties

Journal Articles

The base excision repair enzyme MED1 (MBD4) mediates DNA damage response to anti-tumor drugs and is associated with mismatch repair system integrity

Salvatore Cortellino, David Turner, Filippo Schepis, Valeria Masciullo, Domenico Albino, Rene Daniel, Anna Marie Skalka, Neal J. Meropol, Christophe Alberti, Lionel Larue, Alfonso Bellacosa

Cancer Res (2004) 64 (7_Supplement): 610–611.

Published: 01 April 2004

View articletitled, The base excision repair enzyme MED1 (MBD4) mediates DNA damage response to anti-tumor drugs and is associated with mismatch repair system integrity

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5471: PRT2527, a novel highly selective cyclin-dependent kinase 9 (CDK9) inhibitor, is active in preclinical models of prostate cancer

Abstract LB-201: ERG lysine methylation promotes prostate cancer progression in ERG transgenic mice

Abstract 2900: Sigma-1 receptor control tumorigenic and stem cell-like phenotype in human cancers

Abstract LB-152: EZH2-induced lysine methylation and ERG-EZH2 genomic co-occupancy set the basis for extensive transcriptome reprogramming and prostate cancer progression

Abstract 3343: Targeting the Lin28A/B axis reverts stem cell-like phenotype and tumor-initiating properties in prostate cancer

Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer

Abstract 2625: Targeting prostate cancer stem cells (CSCs) with the novel BET bromodomain (BRD) protein inhibitor OTX015

Abstract 4968: microRNA-mediated silencing of COP1 and altered ubiquitination of key oncogenic transcription factors promote cancer stem cell (CSC) phenotype and prostate cancer progression

Abstract 1451: MicroRNAs regulated by ESE3/EHF control important mediators of epithelial cell differentiation and stemness in prostate tumors

Abstract 1936: The ETS factor ESE3/EHF controls Lin28A and Lin28B and acts as a barrier for stemness in prostate epithelial cells

RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer

ETS Transcription Factor ESE1/ELF3 Orchestrates a Positive Feedback Loop That Constitutively Activates NF-κB and Drives Prostate Cancer Progression

Abstract B24: Loss of expression of the endogenous ETS factor ESE3/EHF is associated with a distinct tumor subtype with stem-like and basal cell features

Abstract 3307: Transcriptional silencing of c-Myc by promoter-directed siRNA efficiently target prostate cancer stem cells.

Abstract 3118: ESE1/ELF3 and constitutive activation of NF-kB in human prostate cancer: prognostic relevance and rationale for context-dependent therapeutic strategies.

ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features

Abstract 5019: Loss of the ETS transcription factor ESE3 induces epithelial-mesenchimal transition and generates cells with stem cell-like properties

The base excision repair enzyme MED1 (MBD4) mediates DNA damage response to anti-tumor drugs and is associated with mismatch repair system integrity

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only